MoonLake Immunotherapeutics (MLTX) Goodwill & Intangibles (2020)
MoonLake Immunotherapeutics (MLTX) posted quarterly Goodwill & Intangibles of $5.0 million for Q4 2020.
Analysis
MoonLake Immunotherapeutics (MLTX) Goodwill & Intangibles (2020) Analysis & Trends
MoonLake Immunotherapeutics' Goodwill & Intangibles history runs 1 years deep, the most recent figure standing at $5.0 million for Q4 2020.
- In Q4 2020, Goodwill & Intangibles changed N/A year-over-year to $5.0 million; the TTM figure through Dec 2020 stood at $5.0 million (changed N/A YoY), while the FY2020 annual figure was $5.0 million, changed N/A from the prior year.
- Goodwill & Intangibles for Q4 2020 stood at $5.0 million.
- The five-year high for Goodwill & Intangibles was $5.0 million in Q4 2020, with the low at $5.0 million in Q4 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.43 Bn | 130.58 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.34 Bn | 58.15 Bn | 1.37 Bn |
| 4 | Moderna | 57.98 Bn | 52.85 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - |
| 6 | BeOne Medicines | 39.92 Bn | 34.82 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.42 Bn | 32.11 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - |
| 9 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn |
| 10 | MoonLake Immunotherapeutics | 1.11 Bn | 568.74 Mn | - |